Keyphrases
Alzheimer's Disease
53%
Light Reflex
38%
Pupillometry
38%
Memory Clinic
31%
Dementia with Lewy Bodies
27%
Short-term Variability
25%
Prognostic Value
25%
Neurofilament Light (NF-L)
21%
Brain-inspired
19%
Cognitive Decline
17%
Longitudinal Cohort Study
15%
P-tau217
14%
Plasma Biomarkers
13%
Anti-IgLON5 Disease
12%
Proof of Concept Study
12%
Test-retest Reliability
12%
Homozygosity
12%
Codon 129
12%
Frontotemporal Dementia
12%
Prion Protein Gene
12%
Motor Function
12%
Quantitative Measurement
12%
Variably Protease-sensitive Prionopathy (VPSPr)
12%
Methionine
12%
Diagnostic Performance
12%
Chain Level
12%
Serum Neurofilament Light Chain
12%
Early Alzheimer's Disease
12%
Short-term Change
12%
Neuroimaging Studies
12%
Longitudinal Clinical Study
12%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
10%
Healthy Controls
9%
Phosphorylated tau
8%
Clinical Dementia Rating
7%
Mini-Mental State Examination
6%
Dementia
6%
Cerebrospinal Fluid
6%
Motor Dysfunction
6%
Rapidly Progressive Dementia
6%
Pronation-supination
6%
Clinical Ratings
6%
Q-Motor
6%
Digital Biomarkers
6%
Confidence Interval
5%
Blood Biomarkers
5%
Neurodegenerative Diseases
5%
Logistic Regression Model
5%
Neuroscience
Alzheimer's Disease
100%
Blood Plasma
38%
Dementia with Lewy Bodies
30%
Neurodegenerative Disorder
14%
Frontotemporal Dementia
12%
Codon
12%
Prion Protein
12%
Proteinase
12%
Methionine
12%
Actigraphy
12%
Neurofilament Light Chain
12%
Fluorine-18
12%
Clinical Dementia Rating
10%
Positron Emission Tomography
10%
Pupillary Reflex
8%
Neurofilament
7%
Stereotypic Movement Disorder
6%
Body Mass Index
6%
Medicine and Dentistry
Alzheimer's Disease
38%
Diffuse Lewy Body Disease
27%
Pupillometry
25%
Motor Performance
12%
Systematic Review
12%
Frontotemporal Lobar Degeneration
12%
Disease
12%
Diagnostic Performance
12%
Cohort Analysis
12%
Diagnosis
8%
Biological Marker
8%
Symptom
7%
Stereotypic Movement Disorder
7%
Pronation
6%
Supination
6%
Patient with Alzheimer's Disease
5%
Logistic Regression Analysis
5%
Cross Sectional Study
5%